Browsing by Author "4f33c252-7221-44d3-9fc5-4e68a9167c70"

Now showing items 1-4 of 4

    • Applicability of ENCHANTED trial results to current acute ischemic stroke patients eligible for intravenous ... 
      Robinson, Thompson G.; Bray, Benjamin D.; Paley, Lizz; Sprigg, Nikola; Wang, Xia; Arima, Hisatomi; Bath, Philip M.; Broderick, Joseph P.; Durham, Alice C.; Kim, Jong S.; Lavados Germain, Pablo Manuel; Lee, Tsong Hai; Martins, Sheila; Nguyen, Thang H.; Pandian, Jeyaraj D.; Parsons, (SAGE Publications Inc., 2019)
      Background: Randomized controlled trials provide high-level evidence, but the necessity to include selected patients may limit the generalisability of their results. Methods: Comparisons were made of baseline and outcome ...
    • Low dose vs standard dose alteplase for patients with acute ischemic stroke secondary analysis of the ... 
      Wang, Xia; Robinson, Thompson G.; Lee, Tsong-Hai; Lavados Germain, Pablo Manuel (American Medical Association, 2017)
      IMPORTANCE: A lower dose of intravenous alteplase appears to be a safer treatment option than the standard dose, reducing the risk of symptomatic intracerebral hemorrhage. There is uncertainty, however, over how this effect ...
    • Low-versus standard-dose alteplase in patients on prior antiplatelet therapy: the Enchanted trial (enhanced ... 
      Robinson, Thompson G.; Wang, Xia; Arima, Hisatomi; Bath, Philip M.; Billot, Laurent; Broderick, Joseph P.; Demchuk, Andrew M.; Donnan, Geoffery A.; Kim, Jong S.; Lavados Germain, Pablo Manuel; Lee, Tsong Hai; Lindley, Richard I.; Martins, Sheila C. O.; Olavarria, Veronica V.; Pandian, Jeyaraj D.; Parsons, Mark W.; Pontes Neto, Octavio M.; Ricci, Stefano; Sato, Shoichiro; Sharma, Vijay K.; Nguyen, Thang H.; Wang, Ji Guang; Woodward, Mark; Chalmers, John; Anderson, Craig S. (Lippincott Williams & Wilkins, 2017)
      Background and Purpose-Many patients receiving thrombolysis for acute ischemic stroke are on prior antiplatelet therapy (APT), which may increase symptomatic intracerebral hemorrhage risk. In a prespecified subgroup analysis, ...
    • Withdrawal of active treatment after intracerebral haemorrhage in the INTERACT2 study 
      Venturelli, Paula Muñoz; Wang, Xia; Zahuranec, Darin B.; Lavados Germain, Pablo Manuel; Stapf, Christian; Lindley, Richard; Delcourt, Candice; Chalmers, John; Anderson, Craig S.; Robinson, Thompson G.; Robinson, Thompson G. (Oxford University Press, 2017)
      © The Author 2016. Published by Oxford University Press on behalf of the British Geriatrics Society. Background: in the second Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT2), a minority ...